26 results
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
of operations and prospects.
If Elicio or any CMOs and suppliers it engages fail to comply with environmental, health, and safety laws and regulations … and any CMOs and suppliers it engages are subject to numerous federal, state, and local environmental, health, and safety laws, regulations
424B3
ELTX
Elicio Therapeutics Inc.
28 Apr 23
Prospectus supplement
4:07pm
, if health or safety issues arise, if public use of the invention is in jeopardy, or if other legal requirements are not satisfied. Although, to Angion’s … and prospects.
If Elicio or any CMOs and suppliers it engages fail to comply with environmental, health, and safety laws and regulations, Elicio could become
S-4/A
EX-10.25
zphtj1q0u5j2x58w4ofi
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.34
in6z4
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
eet3mg3o0unz48
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
DEF 14A
0fyood1
27 Apr 22
Definitive proxy
4:04pm
10-Q
nlot5681lfnok27
17 May 21
Quarterly report
6:03am
10-K
oea4z22
30 Mar 21
Annual report
5:00pm
424B4
xq1 m8dwvk69ndj38l
5 Feb 21
Prospectus supplement with pricing info
5:12pm